1. Home
  2. Analysis
  3. Lisinopril
  4. Dalvance

Lisinopril and Dalvance drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lisinopril (lisinopril) and Dalvance (dalbavancin hydrochloride). Common drug interactions include anaphylactic reaction among females and rash among males.

The phase IV clinical study analyzes what interactions people have when they take Lisinopril and Dalvance. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Lisinopril?

Lisinopril has active ingredients of lisinopril. It is often used in high blood pressure. eHealthMe is studying from 358,654 Lisinopril users. Check the latest studies of Lisinopril.

What is Dalvance?

Dalvance has active ingredients of dalbavancin hydrochloride. eHealthMe is studying from 602 Dalvance users. Check the latest studies of Dalvance.

On Jul, 12, 2026

11 people who take Lisinopril and Dalvance together, and have interactions are studied.

Lisinopril and Dalvance drug interactions.

What are the common drug interactions of Lisinopril and Dalvance, by gender? *:

female:

  1. Anaphylactic reaction (serious allergic reaction)
  2. Anxiety
  3. Angioedema (rapid swelling of the dermis)
  4. Erythema (redness of the skin)
  5. Hypersensitivity
  6. Breath holding
  7. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  8. Dizziness
  9. Intra-abdominal haematoma (intra-abdominal localized swelling filled with blood)
  10. Platelet count decreased

male:

  1. Rash
  2. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  3. Erythema (redness of the skin)
  4. Hypersensitivity
  5. Injection site pain
  6. Peripheral swelling
  7. Pruritus (severe itching of the skin)

What are the common drug interactions of Lisinopril and Dalvance, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Rash

40-49:

n/a

50-59:

  1. Hypersensitivity

60+:

  1. Erythema (redness of the skin)
  2. Pruritus (severe itching of the skin)
  3. Injection site pain
  4. Intra-abdominal haematoma (intra-abdominal localized swelling filled with blood)
  5. Peripheral swelling
  6. Platelet count decreased
  7. Rash
  8. Angioedema (rapid swelling of the dermis)
  9. Hypersensitivity
  10. Lip swelling

What are the existing conditions these people have? *

  1. Cellulitis (infection under the skin): 9 people, 81.82%
  2. Skin Infection: 1 person, 9.09%
  3. Joint Swelling: 1 person, 9.09%
  4. Hyperlipidaemia (presence of excess lipids in the blood): 1 person, 9.09%
  5. Hospitalisation: 1 person, 9.09%
  6. Abscess Limb (limb infection): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Lisinopril and Dalvance?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lisinopril and Dalvance:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lisinopril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Dalvance:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lisinopril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dalvance and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on lisinopril and dalbavancin hydrochloride (the active ingredients of Lisinopril and Dalvance, respectively), and Lisinopril and Dalvance (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.